Clinical trial
Combination Chemotherapy With or Without Amifostine in Treating Patients With…
NCT00003143 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003143 |
|---|---|
| Title | Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation |
| Official title | A Randomized Study of Ethyol (Amifostine) With Platinum Based Salvage Chemotherapy in Patients With Lymphoma Undergoing Autologous Stem Cell Transplantation |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | Amifostine, DHAP |
| Enrollment | 20 |
| Start date | Nov 1, 1997 |
| Primary completion | Dec 1, 2000 |
| First posted | Jun 16, 2004 |
| Last update posted | Oct 4, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: